BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 11587164)

  • 1. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
    Siegel D; Lopez J; Meier J; Cunningham F
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic treatment of hypertension in the Department of Veterans Affairs during 1995 and 1996.
    Siegel D; Lopez J; Meier J
    Am J Hypertens; 1998 Nov; 11(11 Pt 1):1271-8. PubMed ID: 9832168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antihypertensive medication use in the Department of Veterans Affairs: a national analysis of prescribing patterns from 2000 to 2002.
    Lopez J; Meier J; Cunningham F; Siegel D
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1095-9. PubMed ID: 15607614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of national guidelines on antihypertensive prescribing patterns.
    Siegel D
    Curr Hypertens Rep; 2000 Jun; 2(3):247-52. PubMed ID: 10981157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Following evidence-based prescribing guidelines for antihypertensives could save big bucks.
    Rollins G
    Rep Med Guidel Outcomes Res; 2004 Jun; 15(11):1, 6-7. PubMed ID: 15241883
    [No Abstract]   [Full Text] [Related]  

  • 6. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Commission on the Detection, Evaluation, and Treatment of High Blood Pressure.
    Siegel D; Lopez J
    JAMA; 1997 Dec; 278(21):1745-8. PubMed ID: 9388150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Are the newer antihypertensive agents better and more effective than diuretics?].
    Landmark K
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):701-5. PubMed ID: 11293353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
    Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Containing the costs of managing hypertension.
    Arnolda L
    Med J Aust; 2001 Jun; 174(11):556-7. PubMed ID: 11453324
    [No Abstract]   [Full Text] [Related]  

  • 10. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
    Moser M
    Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild-to-moderate uncomplicated hypertension: further analysis of a cost-effectiveness study of five drugs.
    Richter A; Gondek K; Ostrowski C; Dombeck M; Lamb S
    Manag Care Interface; 2001 Jul; 14(7):61-9. PubMed ID: 11481819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
    Stafford RS; Monti V; Furberg CD; Ma J
    Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing patterns of initial drug therapy for the treatment of hypertension in a Medicaid population, 1997-2000.
    Weiss R; Buckley K; Clifford T
    Clin Ther; 2002 Sep; 24(9):1451-62. PubMed ID: 12380636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
    Okano GJ; Rascati KL; Wilson JP; Remund DD; Grabenstein JD; Brixner DI
    Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing costs and improving hypertension management.
    Stankus V; Hemmelgarn B; Campbell NR; Chen G; McAlister FA; Tsuyuki RT
    Can J Clin Pharmacol; 2009; 16(1):e151-5. PubMed ID: 19193969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study.
    Rouette J; McDonald EG; Schuster T; Brophy JM; Azoulay L
    BMJ Open; 2022 Jun; 12(6):e057510. PubMed ID: 35688595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing patterns and therapeutic implications for diabetic hypertension in Bahrain.
    Al Khaja KA; Sequeira RP; Mathur VS
    Ann Pharmacother; 2001 Nov; 35(11):1350-9. PubMed ID: 11724081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of ALLHAT publication on antihypertensive prescribing patterns in Regione Emilia-Romagna, Italy.
    Maio V; Gagne JJ
    J Clin Pharm Ther; 2010 Feb; 35(1):55-61. PubMed ID: 20175812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
    Park C; Wang G; Durthaler JM; Fang J
    Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.